Corvus Pharmaceuticals Inc (CRVS) 52-week high is $26.95
Corvus Pharmaceuticals Inc (CRVS) 52-week high is $26.95. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full CRVS research page for quote, filings, and the rest of the model. This satellite exists so “Corvus Pharmaceuticals Inc 52-week high” can rank with the actual number, then send you to /stock/crvs.